Comparison of early wound healing using modified papilla preservation technique between enamel matrix derivative and recombinant human fibroblast growth factor-Reference-Cited by-同舟云学术

Comparison of early wound healing using modified papilla preservation technique between enamel matrix derivative and recombinant human fibroblast growth factor

Published:2023 Issue: Volume:53 Page:
ISSN:2093-2278
Container-title:Journal of Periodontal & Implant Science
language:en
Short-container-title:J Periodontal Implant Sci

Author:

Nakayama Yohei¹²^ORCID,Tabe Shinichi¹^ORCID,Igarashi Kazuma¹^ORCID,Moriya Satoshi¹^ORCID,Katsumata Tsuyoshi¹^ORCID,Kobayashi Ryo¹^ORCID,Nakagawa Shuta¹^ORCID,Nishino Tomoko¹^ORCID,Fukuoka Namiko¹^ORCID,Hosono Kota¹^ORCID,Yamasaki Mai¹^ORCID,Yamazaki Yosuke¹^ORCID,Ogihara-Takeda Moe¹^ORCID,Ito Shoichi¹^ORCID,Saito Yumi¹^ORCID,Yamaguchi Arisa¹^ORCID,Tsuruya Yuto¹^ORCID,Yamazaki-Takai Mizuho¹²^ORCID,Yoshino Shoichi¹^ORCID,Takai Hideki¹²^ORCID,Ogata Yorimasa¹²^ORCID

Affiliation:

1. Department of Periodontology, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, Japan.

2. Research Institute of Oral Science, Nihon University School of Dentistry at Matsudo, Matsudo, Chiba, Japan.

Funder

Japan Society for the Promotion of Science

Publisher

XMLink

Subject

Periodontics,Oral Surgery

Link

https://jpis.org/pdf/10.5051/jpis.2303080154

Reference40 articles.

1. Enamel matrix derivative (EMDOGAINR) in the treatment of intrabony periodontal defects

2. Enamel matrix proteins; old molecules for new applications

3. Periodontal Tissue Regeneration Using Fibroblast Growth Factor -2: Randomized Controlled Phase II Clinical Trial

4. Randomized Placebo‐Controlled and Controlled Non‐Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects